BRICK nations investing more in pharma R&D, innovation, report says

03/6/2013 | PharmExec.com

Brazil, Russia, India, China and South Korea are investing more in pharmaceutical research and development to bolster their competitiveness, Clark Herman writes. A report from Thomson Reuters finds that while China leads the BRICK nations in production and investment, Brazil, Russia and India are performing better at innovation.

View Full Article in:

PharmExec.com

Published in Brief:

SmartBrief Job Listings for Health Care